Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply.

Lenfant, Matthias; Verstockt, Bram; Sabino, João; Vermeire, Séverine; Ferrante, Marc

Lenfant, Matthias; Verstockt, Bram; Sabino, João; Vermeire, Séverine; Ferrante, Marc.

Afiliación

Lenfant M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Verstockt B; Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium.
Sabino J; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Vermeire S; Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium.
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

Aliment Pharmacol Ther ; 59(5): 723-724, 2024 03.

Article en En | MEDLINE | ID: mdl-38349707

Asunto(s)

Colitis Ulcerosa; Humanos; Colitis Ulcerosa/diagnóstico; Colitis Ulcerosa/genética

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google